Steven Alden
Psychiatric/Mental Health · Carlsbad, CANPI 1427572700
Payments from drug & device makers
Across 196 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lundbeck LLC$614
- Sunovion Pharmaceuticals Inc.$451
- Alkermes, Inc.$306
- Neurocrine Biosciences, Inc.$276
- Supernus Pharmaceuticals, Inc.$215
- plus $360 from 5 others
What the payments were for
- Food & beverage$3,20398%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 74 | $1,049 |
| Lundbeck LLC | 57 | $614 |
| Sunovion Pharmaceuticals Inc. | 27 | $451 |
| Alkermes, Inc. | 7 | $306 |
| Neurocrine Biosciences, Inc. | 7 | $276 |
| Supernus Pharmaceuticals, Inc. | 10 | $215 |
| Otsuka America Pharmaceutical, Inc. | 4 | $137 |
| AbbVie | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Alfasigma USA, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,271 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 13 | $34,933 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 54 | $2,675 |
| KlonopinClonazepam | 13 | $2,615 |
| Bupropion XlBupropion Hcl | 72 | $2,615 |
| Lamotrigine ErLamotrigine | 23 | $1,159 |
| Gabapentin | 42 | $844 |
| Quetiapine Fumarate | 69 | $712 |
| Trazodone Hcl | 65 | $687 |
| Hydroxyzine Hcl | 21 | $528 |
| Fluoxetine Hcl | 44 | $462 |
| Buspirone Hcl | 32 | $423 |
| Paroxetine Hcl | 11 | $358 |
| Escitalopram Oxalate | 48 | $341 |
| Amitriptyline Hcl | 27 | $331 |
| Sertraline Hcl | 18 | $259 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $137 | $34,93313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Carlsbad
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.